Emerging use of hyaluronidase in dermatology

International Journal of DermatologyVolume 63, Issue 9 p. 1126-1127 Commentary Emerging use of hyaluronidase in dermatology Laura Lászik, Corresponding Author Laura Lászik [email protected] orcid.org/0009-0006-1367-6466 Department of Dermatology and Allergology, University of Szeged, Albert Szent-Györgyi Health Center, Szeged, Hungary Correspondence Laura Lászik Department of Dermatology and Allergology University of Szeged Koranyi str. 6 Szeged H-6720 Hungary E-mail: [email protected]Search for more papers by this authorMagdolna Gaál, Magdolna Gaál orcid.org/0000-0002-3198-3877 Department of Dermatology and Allergology, University of Szeged, Albert Szent-Györgyi Health Center, Szeged, HungarySearch for more papers by this author Laura Lászik, Corresponding Author Laura Lászik [email protected] orcid.org/0009-0006-1367-6466 Department of Dermatology and Allergology, University of Szeged, Albert Szent-Györgyi Health Center, Szeged, Hungary Correspondence Laura Lászik Department of Dermatology and Allergology University of Szeged Koranyi str. 6 Szeged H-6720 Hungary E-mail: [email protected]Search for more papers by this authorMagdolna Gaál, Magdolna Gaál orcid.org/0000-0002-3198-3877 Department of Dermatology and Allergology, University of Szeged, Albert Szent-Györgyi Health Center, Szeged, HungarySearch for more papers by this author First published: 30 August 2024 https://doi.org/10.1111/ijd.17418 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Murray G, Convery C, Walker L, Davies E. Guideline for the management of hyaluronic acid filler-induced vascular occlusion. J Clin Aesthet Dermatol. 2021; 14: E61–E69. PubMedGoogle Scholar 2Kadouch J, Schelke L, Groh O, Sokol V, Velthuis P. Intralesional hyaluronidase injection to relieve non-hyaluronic acid filler-induced vascular adverse events. Int J Dermatol. 2024; 63: 1252–1255. https://doi.org/10.1111/ijd.17355 10.1111/ijd.17355 Google Scholar 3Searle T, Ali FR, Al-Niaimi F. Hyaluronidase in dermatology: uses beyond hyaluronic acid fillers. J Drugs Dermatol. 2020; 19: 993–998. https://doi.org/10.36849/JDD.2020.5416 10.36849/JDD.2020.5416 PubMedGoogle Scholar 4Dursun R, Altay E, Temiz SA. Intralesional hyaluronidase as a treatment for fibrosis in hidradenitis suppurativa: a case report. Int J Dermatol. 2024. https://doi.org/10.1111/ijd.17312 10.1111/ijd.17312 PubMedGoogle Scholar 5Pulumati A, Algarin Y, Jaalouk D, Latta S, Nouri K. Fillers impacting follicles: the emerging complication of filler-induced alopecia. Int J Dermatol. 2024; 63: 1131–1139. https://doi.org/10.1111/ijd.17169 10.1111/ijd.17169 Google Scholar Volume63, Issue9September 2024Pages 1126-1127 ReferencesRelatedInformation